Tag: Zydus Life Sciences
Zydus Lifesciences Q4 net profit rises 18% on strong US, India...
Consolidated revenue from operations rose 18% YoY to Rs 6,528 crore, while EBITDA surged 30% to Rs 2126 crore
Zydus to develop world’s first combination vaccine against shigellosis & typhoid...
The project is expected to get underway in March 2025, and is being supported by the Gates Foundation
Zydus partners Synthon to develop & commercialize novel oncology product in...
This 505(B)(2) Oncology product will likely be filed in 2026 and will be offering additional strengths that is intended to provide reduced pill burden, flexibility for dose adjustment
Zydus acquires UK based LiqMeds
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026 depending on achievement of certain agreed milestones towards acquisition of the LiqMeds Group of companies